Yildiz Abdulkadir, Gucuk Esra, Cay Serkan
Department of Cardiology, Yuksek Ihtisas Heart-Education and Research Hospital, Ankara, Turkey.
Acta Cardiol. 2008 Aug;63(4):515-7. doi: 10.2143/AC.63.4.2033052.
Fibrates either alone or in combination with statins have been commonly used for the treatment of high non-HDL-cholesterol levels. In addition, this type of therapy is also associated with some adverse events like rhabdomyolysis. We present the first case in the literature describing the development of both rhabdomyolysis-induced acute renal failure and thromboembolic event under the treatment of fibrate monotherapy.